Your Article Summary
See Latest ArticlesSarcoidosis Appearing During Anti-Tumor Necrosis Factor alpha Therapy: A New “Class Effect” Paradoxical Phenomenon. Two Case Reports and Literature Review
Seminars in Arthritis and Rheumatism, 07/01/09
Massara A et al. - The development of sarcoidosis during treatment with TNF-alpha antagonists represents a rare and paradoxical adverse event. The occurrence of sarcoidosis with all 3 available agents suggests a new “class effect” probably linked to a cytokine disequilibrium in patients receiving anti-TNF-alpha treatment.
Related Articles
The role of EBUS-TBNA for the diagnosis of sarcoidosis – comparisons with other bronchoscopic diagnostic modalities
Respiratory Medicine, 11/18/09
Relevance Score: 89%
Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
American Journal of Respiratory and Critical Care Medicine, 11/13/09
Relevance Score: 89%
The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis
European Respiratory Journal, 11/11/09
Relevance Score: 89%
Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09
Relevance Score: 88%
Sarcoidosis of the submandibular gland: A systematic review
American Journal of Otolaryngology, 10/15/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignancy-associated multicentric reticulohistiocytosis
Rheumatology International, 12/20/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: A case series
Rheumatology, 12/18/09